Novel Therapeutic Targets for Allergic Airway Disease in Children

Overview

Journal Drugs Context

Specialty Pharmacology

Date 2019 Aug 9

PMID 31391855

Citations 3

Authors

Alessandro Giallongo

Giuseppe Fabio Parisi

Amelia Licari

Giulio Pulvirenti

Caterina Cuppari

Carmelo Salpietro

Gian Luigi Marseglia

Salvatore Leonardi

Affiliations

Soon will be listed here.

Abstract

The aim of precision medicine is setting up targeted therapies for selected patients that would ideally have high effectiveness and few side effects. This is made possible by targeted therapy drugs that selectively act on a specific pathway. Precision medicine is spreading to many medical specialties, and there is increasing interest in the context of allergic airway diseases, such as allergic rhinitis, chronic rhinosinusitis, and asthma. This review is an update of new targets in the treatment of childhood allergic upper airway diseases and asthma, including the most recent biologic drugs that have already been licensed or are in the pipeline to be tested with children.

Citing Articles

Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review.

Manti S, Giallongo A, Parisi G, Papale M, Mule E, Aloisio D Eur Respir Rev. 2022; 31(165).

PMID: 35896271 PMC: 9724814. DOI: 10.1183/16000617.0011-2022.

Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon.

Manti S, Pecora G, Patane F, Giallongo A, Parisi G, Papale M Nutrients. 2021; 13(7).

PMID: 34371821 PMC: 8308414. DOI: 10.3390/nu13072314.

Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review.

Manti S, Parisi G, Papale M, Marseglia G, Licari A, Leonardi S Immun Inflamm Dis. 2021; 9(1):3-7.

PMID: 33434384 PMC: 7860524. DOI: 10.1002/iid3.384.

References

Simons F . Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999; 104(3 Pt 1):534-40. DOI: 10.1016/s0091-6749(99)70320-9. View

Passalacqua G, Ciprandi G, Canonica G . United airways disease: therapeutic aspects. Thorax. 2000; 55 Suppl 2:S26-7. PMC: 1765974. DOI: 10.1136/thorax.55.suppl_2.s26. View

Leckie M, Ten Brinke A, Khan J, Diamant Z, OConnor B, Walls C . Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2001; 356(9248):2144-8. DOI: 10.1016/s0140-6736(00)03496-6. View

Lombardi C, Passalacqua G, Gargioni S, Senna G, Ciprandi G, Scordamaglia A . The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years. Respir Med. 2001; 95(1):9-12. DOI: 10.1053/rmed.2000.0945. View

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M . Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001; 108(2):E36. DOI: 10.1542/peds.108.2.e36. View

Busse W, Corren J, Lanier B, McAlary M, Fowler-Taylor A, Cioppa G . Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001; 108(2):184-90. DOI: 10.1067/mai.2001.117880. View

Soler M, Matz J, Townley R, Buhl R, OBrien J, Fox H . The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J. 2001; 18(2):254-61. DOI: 10.1183/09031936.01.00092101. View

Casale T, Condemi J, Laforce C, Nayak A, Rowe M, Watrous M . Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA. 2001; 286(23):2956-67. DOI: 10.1001/jama.286.23.2956. View

Moller C, Dreborg S, Ferdousi H, Halken S, Host A, Jacobsen L . Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002; 109(2):251-6. DOI: 10.1067/mai.2002.121317. View

10.

Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, von Berg A . Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol. 2002; 109(2):274-80. DOI: 10.1067/mai.2002.121949. View

11.

Douwes J, Gibson P, Pekkanen J, Pearce N . Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002; 57(7):643-8. PMC: 1746367. DOI: 10.1136/thorax.57.7.643. View

12.

Green R, Brightling C, McKenna S, Hargadon B, Parker D, Bradding P . Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360(9347):1715-21. DOI: 10.1016/S0140-6736(02)11679-5. View

13.

Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L . Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy. 2003; 33(2):206-10. DOI: 10.1046/j.1365-2222.2003.01587.x. View

14.

Leynaert B, Neukirch C, Kony S, Guenegou A, Bousquet J, Aubier M . Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004; 113(1):86-93. DOI: 10.1016/j.jaci.2003.10.010. View

15.

Bel E . Clinical phenotypes of asthma. Curr Opin Pulm Med. 2004; 10(1):44-50. DOI: 10.1097/00063198-200401000-00008. View

16.

Hallstrand T, Sprenger J, Agosti J, Longton G, Witherspoon R, Henderson Jr W . Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood. 2004; 104(10):3086-90. DOI: 10.1182/blood-2004-05-1775. View

17.

Schulze T, McMahon F . Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered. 2005; 58(3-4):131-8. DOI: 10.1159/000083539. View

18.

Smith A, Cowan J, Brassett K, Filsell S, McLachlan C, Monti-Sheehan G . Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005; 172(4):453-9. DOI: 10.1164/rccm.200411-1498OC. View

19.

Romagnani S . Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?. Allergy. 2005; 61(1):3-14. DOI: 10.1111/j.1398-9995.2006.01005.x. View

20.

Niggemann B, Jacobsen L, Dreborg S, Ferdousi H, Halken S, Host A . Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006; 61(7):855-9. DOI: 10.1111/j.1398-9995.2006.01068.x. View